Read more

February 09, 2021
1 min read
Save

NKF awards researcher focused on hypertension, kidney disease prevention

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Paul K. Whelton, MB, MD, MSc, of Tulane University School of Public Health and Tropical Medicine, will receive the National Kidney Foundation’s David M. Hume Memorial Award at the 2021 Spring Clinical Meetings.

According to a press release from the NKF, the award is the “highest honor” given by the foundation and is reserved for those who exemplify both scholarship and humanitarianism in their work.

Kidneys
Source: Adobe Stock

“Dr. Whelton is highly deserving of this award in Dr. Hume’s name,” Paul Palevsky, MD, president of the NKF, said in the release. “His contributions, in particular his focus on public health and his leadership of numerous studies of the treatment of high blood pressure, aligns perfectly with the standards set by Dr. Hume.”

The release emphasized Whelton’s extensive background, including chairing many clinical trials (Trial of Nonpharmacologic Interventions in the Elderly, for example) publishing more than 500 peer-reviewed manuscripts and receiving numerous awards (eg, the American Heart Association Population Research Prize in 2007). He has served in many roles throughout his career and is the Show Chwan Health System Endowed Chair in Global Public Health at Tulane.

Paul K. Whelton

“As an academic nephrologist on the faculty at Johns Hopkins, I was drawn to the potential of clinical epidemiology and prevention sciences to transform the care of patients with kidney disease and reduce the ever-expanding kidney disease burden in the general population,” Whelton said in the release. “One of my earliest national presentations was at an NKF meeting and I have always had great admiration for the contributions of the organization to kidney disease patients and kidney disease professionals.”

Whelton also provided his thoughts on receiving the Hume award, calling it a “special honor.”

“Dr. Hume was an extraordinary role model whose innovations and contributions transformed care for patients with advanced kidney disease,” Whelton said. “He was an inspiration to me and others of my generation. I feel privileged and fortunate to receive the NKF award that bears his name.”